Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.8%

1 terminated out of 21 trials

Success Rate

87.5%

+0.9% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed with results

Key Signals

1 with results88% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (8)
P 1 (1)
P 2 (3)

Trial Status

Completed7
Recruiting4
Unknown3
Not Yet Recruiting2
Withdrawn2
Active Not Recruiting2

Trial Success Rate

87.5%

Benchmark: 86.6%

Based on 7 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT07155525Not ApplicableRecruiting

Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas

NCT07845617Recruiting

Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma

NCT07796997Phase 1Not Yet Recruiting

GI-06: The Impact of Perioperative Hydrocortisone on Patients Undergoing Partial Pancreatectomy

NCT06453590Not ApplicableActive Not Recruiting

Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents

NCT06414122Not ApplicableNot Yet Recruiting

Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients

NCT02012699Recruiting

Integrated Cancer Repository for Cancer Research

NCT03631173Not ApplicableActive Not Recruiting

Monitoring of patIents With Microdialysis Following Pancreaticoduodenectomy

NCT06690281Phase 2Withdrawn

A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies

NCT05251233Phase 2Terminated

Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy

NCT04104230Recruiting

Quebec Pancreas Cancer Study

NCT05134961CompletedPrimary

Long-term Outcomes After Resection of Primary Duodenal Adenocarcinoma

NCT03346980Completed

Endoscopic Evaluation of Duodenal Polyposis in Patients With Familial Adenomatous Polyposis (FAP)

NCT03139487Phase 2Unknown

A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

NCT03525067Completed

Colonization of Bile Ducts and Postoperative Infectious Complications of Pancreaticoduodenectomies

NCT01438385Unknown

Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders

NCT02446379Withdrawn

Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery

NCT02954302Not ApplicableUnknown

Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticoduodenectomy

NCT01838109Not ApplicableCompleted

Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery

NCT01661049CompletedPrimary

Duodenal Cancer - Retrospective Analysis

NCT00639314Not ApplicableCompleted

Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy

Scroll to load more

Research Network

Activity Timeline